Painreform is trading 5.45% down at $1.04, with no confirmed company-specific catalyst identified.

  • Opened below the August 11, 2026 close of $1.10.
  • Coverage identifies no recent press release, earnings release, regulatory action, or analyst event.
  • Broader U.S. markets are higher; the move appears driven by limited liquidity or stock-specific trading pressure, but the cause remains unconfirmed.